BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚ฌ1.37 B
Marketcap
6,52ย โ‚ฌ
Share price
-3.07%
Change (1 day)
-9.49%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of September 2025 : -โ‚ฌ0.34 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -โ‚ฌ0.34 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚ฌ0.46 Billion10.99%
2023-12-31$-โ‚ฌ0.42 Billion50.04%
2022-12-31$-โ‚ฌ0.28 Billion190.72%
2021-12-31$-โ‚ฌ94.47 Million503.24%
2020-12-31$-โ‚ฌ15.67 Million-145.86%
2019-12-31$โ‚ฌ34.14 M-20.66%
2018-12-31$โ‚ฌ43.03 M-38.35%
2017-12-31$โ‚ฌ69.81 M4553.63%
2016-12-31$โ‚ฌ1.5 M-96.56%
2015-12-31$โ‚ฌ43.64 M-29.82%
2014-12-31$โ‚ฌ62.18 M-7727.34%
2013-12-31$-โ‚ฌ0.82 Million137.56%
2012-12-31$-โ‚ฌ0.35 Million-103.01%
2011-12-31$โ‚ฌ11.4 M-76.85%
2010-12-31$โ‚ฌ49.24 M-18.21%
2009-12-31$โ‚ฌ60.21 M81.31%
2008-12-31$โ‚ฌ33.2 M-25.29%
2007-12-31$โ‚ฌ44.45 M177.26%
2006-12-31$โ‚ฌ16.03 M-67.5%
2005-12-31$โ‚ฌ49.33 M128.13%
2004-12-31$โ‚ฌ21.62 M-4.29%
2003-12-31$โ‚ฌ22.59 M-41.14%
2002-12-31$โ‚ฌ38.38 M-40.33%
2001-12-31$โ‚ฌ64.33 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
โ‚ฌ1.78 B-637.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.13 B-440.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ6.45 M-101.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ0.14 Billion-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ18.42 B-5,631.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.51 B-254.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ18.18 B-5,559.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚ฌ0.50 B-250.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ6.03 M-101.81%๐Ÿ‡บ๐Ÿ‡ธ USA